Reduced affinity for Isoniazid in the S315T mutant of Mycobacterium tuberculosis KatG is a key factor in antibiotic resistance
- PMID: 12586821
- DOI: 10.1074/jbc.M300326200
Reduced affinity for Isoniazid in the S315T mutant of Mycobacterium tuberculosis KatG is a key factor in antibiotic resistance
Abstract
Catalase-peroxidase (KatG) from Mycobacterium tuberculosis is responsible for the activation of the antitubercular drug isonicotinic acid hydrazide (INH) and is important for survival of M. tuberculosis in macrophages. Characterization of the structure and catalytic mechanism of KatG is being pursued to provide insights into drug (INH) resistance in M. tuberculosis. Site-directed mutagenesis was used to prepare the INH-resistant mutant KatG[S315T], and the overexpressed enzyme was characterized and compared with wild-type KatG. KatG[S315T] exhibits a reduced tendency to form six-coordinate heme, because of coordination of water to iron during purification and storage, and also forms a highly unstable Compound III (oxyferrous enzyme). Catalase activity and peroxidase activity measured using t-butylhydroperoxide and o-dianisidine were moderately reduced in the mutant compared with wild-type KatG. Stopped-flow spectrophotometric experiments revealed a rate of Compound I formation similar to wild-type KatG using peroxyacetic acid to initiate the catalytic cycle, but no Compound I was detected when bulkier peroxides (chloroperoxybenzoic acid, t-butylhydroperoxide) were used. The affinity of resting (ferric) KatG[S315T] for INH, measured using isothermal titration calorimetry, was greatly reduced compared with wild-type KatG, as were rates of reaction of Compound I with the drug. These observations reveal that although KatG[S315T] maintains reasonably good steady state catalytic rates, poor binding of the drug to the enzyme limits drug activation and brings about INH resistance.
Similar articles
-
Antibiotic resistance in Mycobacterium tuberculosis: peroxidase intermediate bypass causes poor isoniazid activation by the S315G mutant of M. tuberculosis catalase-peroxidase (KatG).J Biol Chem. 2009 Jun 12;284(24):16146-16155. doi: 10.1074/jbc.M109.005546. Epub 2009 Apr 9. J Biol Chem. 2009. PMID: 19363028 Free PMC article.
-
Resonance Raman spectroscopy of Compound II and its decay in Mycobacterium tuberculosis catalase-peroxidase KatG and its isoniazid resistant mutant S315T.J Inorg Biochem. 2005 Jun;99(6):1401-6. doi: 10.1016/j.jinorgbio.2005.03.016. J Inorg Biochem. 2005. PMID: 15917090
-
Conformational differences in Mycobacterium tuberculosis catalase-peroxidase KatG and its S315T mutant revealed by resonance Raman spectroscopy.Biochemistry. 2003 Apr 8;42(13):3835-45. doi: 10.1021/bi026992y. Biochemistry. 2003. PMID: 12667074
-
Impact of isoniazid resistance on virulence of global and south Indian clinical isolates of Mycobacterium tuberculosis.Tuberculosis (Edinb). 2014 Dec;94(6):557-63. doi: 10.1016/j.tube.2014.08.011. Epub 2014 Sep 6. Tuberculosis (Edinb). 2014. PMID: 25270728 Review.
-
The molecular basis of isoniazid resistance in Mycobacterium tuberculosis.Tuber Lung Dis. 1999;79(4):267-71. doi: 10.1054/tuld.1998.0208. Tuber Lung Dis. 1999. PMID: 10692996 Review. No abstract available.
Cited by
-
Antibiotic resistance in Mycobacterium tuberculosis: peroxidase intermediate bypass causes poor isoniazid activation by the S315G mutant of M. tuberculosis catalase-peroxidase (KatG).J Biol Chem. 2009 Jun 12;284(24):16146-16155. doi: 10.1074/jbc.M109.005546. Epub 2009 Apr 9. J Biol Chem. 2009. PMID: 19363028 Free PMC article.
-
Identification and Characterization of Genetic Determinants of Isoniazid and Rifampicin Resistance in Mycobacterium tuberculosis in Southern India.Sci Rep. 2019 Jul 16;9(1):10283. doi: 10.1038/s41598-019-46756-x. Sci Rep. 2019. PMID: 31311987 Free PMC article.
-
Mutation bias shapes the spectrum of adaptive substitutions.Proc Natl Acad Sci U S A. 2022 Feb 15;119(7):e2119720119. doi: 10.1073/pnas.2119720119. Proc Natl Acad Sci U S A. 2022. PMID: 35145034 Free PMC article.
-
The pathogenic mechanism of Mycobacterium tuberculosis: implication for new drug development.Mol Biomed. 2022 Dec 22;3(1):48. doi: 10.1186/s43556-022-00106-y. Mol Biomed. 2022. PMID: 36547804 Free PMC article. Review.
-
Relevance of peroxiredoxins in pathogenic microorganisms.Appl Microbiol Biotechnol. 2021 Aug;105(14-15):5701-5717. doi: 10.1007/s00253-021-11360-5. Epub 2021 Jul 14. Appl Microbiol Biotechnol. 2021. PMID: 34258640 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases